BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15862993)

  • 1. Improvement of ACE inhibitory activity of chitooligosaccharides (COS) by carboxyl modification.
    Huang R; Mendis E; Kim SK
    Bioorg Med Chem; 2005 Jun; 13(11):3649-55. PubMed ID: 15862993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin I converting enzyme (ACE) inhibitory activity of hetero-chitooligosaccharides prepared from partially different deacetylated chitosans.
    Park PJ; Je JY; Kim SK
    J Agric Food Chem; 2003 Aug; 51(17):4930-4. PubMed ID: 12903948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin inhibition activity by chitooligosaccharides.
    Park PJ; Ahn CB; Jeon YJ; Je JY
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2471-4. PubMed ID: 18313296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. tert-Butyldimethylsilyl O-protected chitosan and chitooligosaccharides: useful precursors for N-modifications in common organic solvents.
    Rúnarsson OV; Malainer C; Holappa J; Sigurdsson ST; Másson M
    Carbohydr Res; 2008 Oct; 343(15):2576-82. PubMed ID: 18768174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant activity of N-carboxymethyl chitosan oligosaccharides.
    Sun T; Yao Q; Zhou D; Mao F
    Bioorg Med Chem Lett; 2008 Nov; 18(21):5774-6. PubMed ID: 18842408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitooligosaccharides--preparation with the aid of pectinase isozyme from Aspergillus niger and their antibacterial activity.
    Kittur FS; Vishu Kumar AB; Varadaraj MC; Tharanathan RN
    Carbohydr Res; 2005 May; 340(6):1239-45. PubMed ID: 15797142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of novel angiotensin-I-converting enzyme inhibitory peptides from protease-hydrolyzed marine shrimp Acetes chinensis.
    Hai-Lun H; Xiu-Lan C; Cai-Yun S; Yu-Zhong Z; Bai-Cheng Z
    J Pept Sci; 2006 Nov; 12(11):726-33. PubMed ID: 16981241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory profiles of captopril on matrix metalloproteinase-9 activity.
    Yamamoto D; Takai S; Miyazaki M
    Eur J Pharmacol; 2008 Jul; 588(2-3):277-9. PubMed ID: 18501888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chitooligosaccharides on calcium bioavailability and bone strength in ovariectomized rats.
    Jung WK; Moon SH; Kim SK
    Life Sci; 2006 Jan; 78(9):970-6. PubMed ID: 16137703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
    Shalaby SM; Zakora M; Otte J
    J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of matrix metalloproteinase activity and growth of gastric adenocarcinoma cells by an angiotensin converting enzyme inhibitor in in vitro and murine models.
    Williams RN; Parsons SL; Morris TM; Rowlands BJ; Watson SA
    Eur J Surg Oncol; 2005 Nov; 31(9):1042-50. PubMed ID: 15993560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and characterization of angiotensin I converting enzyme inhibitory peptides from the rotifer, Brachionus rotundiformis.
    Lee JK; Hong S; Jeon JK; Kim SK; Byun HG
    Bioresour Technol; 2009 Nov; 100(21):5255-9. PubMed ID: 19540110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of several acetylated chitooligosaccharides on antioxidation, antiglycation and NO generation in erythrocyte.
    Zhang CM; Yu SH; Zhang LS; Zhao ZY; Dong LL
    Bioorg Med Chem Lett; 2014 Aug; 24(16):4053-7. PubMed ID: 24986658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of varying chain length between P(1) and P(1') position of tripeptidomimics on activity of angiotensin-converting enzyme inhibitors.
    Chaudhary S; Vats ID; Chopra M; Biswas P; Pasha S
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4364-6. PubMed ID: 19523823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial effect of chitooligosaccharides produced by chitosanase from Pseudomonas CUY8.
    Wang Y; Zhou P; Yu J; Pan X; Wang P; Lan W; Tao S
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():174-7. PubMed ID: 17392099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry.
    Wijesekara I; Kim SK
    Mar Drugs; 2010 Mar; 8(4):1080-93. PubMed ID: 20479968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of rice protein hydrolysate with in vitro angiotensin I-converting enzyme inhibitory activity in spontaneously hypertensive rats.
    Li GH; Qu MR; Wan JZ; You JM
    Asia Pac J Clin Nutr; 2007; 16 Suppl 1():275-80. PubMed ID: 17392118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble chitosan derivatives as a BACE1 inhibitor.
    Je JY; Kim SK
    Bioorg Med Chem; 2005 Dec; 13(23):6551-5. PubMed ID: 16084727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
    Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
    Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of anti-angiogenic activities of chitooligosaccharides may be through inhibiting heparanase activity.
    Quan H; Zhu F; Han X; Xu Z; Zhao Y; Miao Z
    Med Hypotheses; 2009 Aug; 73(2):205-6. PubMed ID: 19342181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.